Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedNov 01, 2025
DataAggregated Company Financials
Companies159
  • 7D-5.8%
  • 3M20.7%
  • 1Y-19.5%
  • YTD-9.9%

Over the last 7 days, the Healthcare Services industry has dropped 5.8%, driven by a pullback from UnitedHealth Group of 5.8%. In contrast, Cardinal Health has gained 18%. Overall the industry is down 20% in 12 months. As for the next few years, earnings are expected to grow by 18% per annum.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 02 Nov 2025US$888.5bUS$2.1tUS$35.4b21.2x25.1x0.4x
Tue, 30 Sep 2025US$897.0bUS$2.1tUS$49.3b21.2x18.2x0.4x
Thu, 28 Aug 2025US$845.5bUS$2.1tUS$49.3b21.3x17.2x0.4x
Sat, 26 Jul 2025US$779.5bUS$2.1tUS$52.2b19.8x14.9x0.4x
Mon, 23 Jun 2025US$871.1bUS$2.1tUS$52.7b21.8x16.5x0.4x
Wed, 21 May 2025US$895.0bUS$2.1tUS$52.4b21.9x17.1x0.4x
Fri, 18 Apr 2025US$1.1tUS$1.7tUS$49.4b23.1x22x0.6x
Sun, 16 Mar 2025US$988.4bUS$1.7tUS$41.4b23.2x23.8x0.6x
Tue, 11 Feb 2025US$1.0tUS$1.7tUS$41.5b23.7x24.5x0.6x
Thu, 09 Jan 2025US$1.0tUS$2.0tUS$42.3b23.8x24.3x0.5x
Sat, 07 Dec 2024US$1.1tUS$2.0tUS$41.4b23.9x27.2x0.6x
Mon, 04 Nov 2024US$1.1tUS$1.9tUS$43.5b23.9x25.9x0.6x
Wed, 02 Oct 2024US$1.2tUS$1.9tUS$43.3b25.1x27.8x0.6x
Fri, 30 Aug 2024US$1.2tUS$1.9tUS$43.3b26.4x28.2x0.6x
Sun, 28 Jul 2024US$1.2tUS$1.9tUS$43.3b27.2x27.5x0.6x
Tue, 25 Jun 2024US$1.1tUS$1.9tUS$43.4b25.4x25x0.6x
Thu, 23 May 2024US$1.1tUS$1.9tUS$43.5b26.4x25.8x0.6x
Sat, 20 Apr 2024US$1.1tUS$1.9tUS$43.0b25.3x25.6x0.6x
Mon, 18 Mar 2024US$1.1tUS$1.8tUS$50.1b23.9x22.3x0.6x
Wed, 14 Feb 2024US$1.1tUS$1.8tUS$50.4b22.2x22.6x0.6x
Fri, 12 Jan 2024US$1.2tUS$1.8tUS$50.2b24.3x23.5x0.7x
Sun, 10 Dec 2023US$1.2tUS$1.8tUS$51.2b23x22.6x0.6x
Tue, 07 Nov 2023US$1.1tUS$1.8tUS$50.6b21.8x22.5x0.6x
Thu, 05 Oct 2023US$1.1tUS$1.8tUS$46.8b22.1x23.7x0.6x
Sat, 02 Sep 2023US$1.1tUS$1.8tUS$46.7b22.2x23x0.6x
Mon, 31 Jul 2023US$1.1tUS$1.7tUS$47.9b22.7x23.6x0.7x
Wed, 28 Jun 2023US$1.1tUS$1.7tUS$45.8b23.2x24x0.6x
Fri, 26 May 2023US$1.1tUS$1.7tUS$45.7b21.7x23.7x0.6x
Sun, 23 Apr 2023US$1.1tUS$1.4tUS$44.3b24x24x0.7x
Tue, 21 Mar 2023US$1.1tUS$1.4tUS$44.4b22x23.7x0.7x
Thu, 16 Feb 2023US$1.1tUS$1.4tUS$44.2b22.1x25.5x0.8x
Sat, 14 Jan 2023US$1.1tUS$1.4tUS$45.0b21.4x25.2x0.8x
Mon, 12 Dec 2022US$1.2tUS$1.4tUS$44.4b20.7x27.3x0.9x
Wed, 09 Nov 2022US$1.2tUS$1.4tUS$42.0b20x28.8x0.9x
Price to Earnings Ratio

28.8x


Total Market Cap: US$1.2tTotal Earnings: US$42.0bTotal Revenue: US$1.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 23.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the American Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 23.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.61x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 5.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market0.46%
Healthcare-0.75%
Healthcare Services-5.82%
Healthcare Distributors1.09%
Healthcare Facilities-3.24%
Managed Healthcare-5.52%
Healthcare Services-8.61%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry, which is trading close to its 3-year average PE ratio of 38.2x.
    • Analysts are expecting annual earnings growth of 13.6%, which is higher than its past year's earnings growth of 6.3% per year.
  • Investors are most pessimistic about the Healthcare Facilities industry, which is trading below its 3-year average of 21.2x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 28% over the next 5 years.
  • This is better than its past earnings growth rate of 7.5% per year.
  • In contrast, the Healthcare Facilities industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAH Cardinal HealthUS$190.7717.8%
+US$6.9b		64.3%PE28.4x
GH Guardant HealthUS$93.0228.9%
+US$2.7b		304.4%PS13x
MCK McKessonUS$811.341.2%
+US$1.2b		54.1%PE31.9x
COR CencoraUS$337.811.5%
+US$988.8m		44.2%PE34.5x
CNC CenteneUS$35.373.8%
+US$652.1m		-44.3%PS0.1x

Latest News

UHS
US$217.01
Universal Health Services
7D
3.0%
1Y
5.7%
CI
US$244.41
Cigna Group
7D
-19.0%
1Y
-22.8%
EHC
US$113.85
Encompass Health
7D
-9.7%
1Y
15.1%
CNC
US$35.37
Centene
7D
3.8%
1Y
-44.3%
LH
US$253.96
Labcorp Holdings
7D
-9.1%
1Y
11.8%

LH: Share Repurchases And Alzheimer’s Test Launch Will Drive Profits Ahead

Analysts have modestly raised their price target for Labcorp Holdings from $296.18 to $299.12. They cite solid improvements in projected profit margins, which offset slightly lower top-line growth expectations.
GH
US$93.02
Guardant Health
7D
28.9%
1Y
304.4%

Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable

Oct 31
Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable
CAH
US$190.77
Cardinal Health
7D
17.8%
1Y
64.3%

CAH: Core Pharmaceutical Trends And Automation Will Shape Upcoming Earnings Performance

Cardinal Health's analyst price target has increased from $180 to $216 per share. This reflects stronger confidence in the company's core pharmaceutical business and its ability to deliver on long-term earnings targets, according to recent analyst commentary following robust quarterly results.
DVA
US$119.02
DaVita
7D
-7.9%
1Y
-15.9%
MCK
US$811.34
McKesson
7D
1.2%
1Y
54.1%
WGS
US$136.91
GeneDx Holdings
7D
6.2%
1Y
76.1%
UNH
US$341.56
UnitedHealth Group
7D
-5.8%
1Y
-39.8%
CVS
US$78.15
CVS Health
7D
-4.6%
1Y
40.0%
HCA
US$459.68
HCA Healthcare
7D
2.8%
1Y
28.7%

Supplemental Payments And Policy Risks Will Shape Future Performance And Value

HCA Healthcare's fair value estimate has been raised from $417.52 to $471.00. Analysts cite strong quarterly performance, improved profit margins, and the positive impact of supplemental payment approvals as key drivers for the upward revision.
HUM
US$278.19
Humana
7D
-4.3%
1Y
6.7%
ELV
US$317.20
Elevance Health
7D
-7.3%
1Y
-23.4%
COR
US$337.81
Cencora
7D
1.5%
1Y
44.2%